Results

Pharnext SA

10/18/2021 | Press release | Distributed by Public on 10/18/2021 10:05

Data from First Phase III Clinical Study of PXT3003 in Charcot-Marie-Tooth Disease Type 1A, the PLEO-CMT Trial, Published in the Orphanet Journal of Rare Diseases